You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pulmonary disease

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD, Pulmonary Hypertension Trial (Nitric Oxide Generation and Delivery System)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Hypertension
  • Nitric Oxide Generation and Delivery System
  • (no location specified)
Mar 14, 2023

Voice Dataset for Automated Classification of Chronic

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • COPD
  • Karlskrona, Blekinge, Sweden
    Blekinge Institute of Technology
Jun 9, 2023

COPD Trial (Nitric Oxide Generation and Delivery System)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Nitric Oxide Generation and Delivery System
  • (no location specified)
Jun 1, 2023

Acute Exacerbation of COPD Trial in Beijing (Programmed Weaning From Noninvasive Mechanical Ventilation)

Recruiting
  • Acute Exacerbation of COPD
  • Programmed Weaning From Noninvasive Mechanical Ventilation
  • Beijing, Beijing, China
    Peking University Third Hospita
Aug 25, 2023

Acute Exacerbation of COPD Trial in Beijing (Xuanfei Baidu granule, Xuanfei Baidu granule Placebo)

Recruiting
  • Acute Exacerbation of Chronic Obstructive Pulmonary Disease
  • Xuanfei Baidu granule
  • Xuanfei Baidu granule Placebo
  • Beijing, China
    Peking University People's Hospital
Nov 10, 2023

COPD Trial in Rahim Yar Khan (Active cycle of breathing technique, Autogenic drainage)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Active cycle of breathing technique
  • Autogenic drainage
  • Rahim Yar Khan, Punjab, Pakistan
    Sheikh Zayed Hospital,
Jun 26, 2023

Pulmonary Disease, Chronic Obstructive Trial in Anqing (Tai-chi exercise)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Tai-chi exercise
  • Anqing, Anhui, China
    Anqing Hospital Affiliated to Anhui Medical University
Aug 12, 2023

Balance in Patients With Chronic Obstructive Pulmonary Disease

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Balance Assessment
  • +5 more
  • Istanbul, Turkey
    Biruni University
Mar 6, 2023

COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • HRG2005 inhalation
  • +3 more
  • (no location specified)
Sep 7, 2023

Self-developed Pulmonary Lobar Ventilation Detector

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • Self-developed pulmonary lobar ventilation detector
  • Chartis detection system
  • (no location specified)
Mar 22, 2023

Pulmonary Diseases, Ophthalmological Diagnostic Techniques, Artificial Intelligence Trial in Guangzhou (Ophthalmic examination,

Not yet recruiting
  • Pulmonary Diseases
  • +2 more
  • Ophthalmic examination
  • Pulmonary Examination
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
May 5, 2023

COPD Trial in Paris (BORA Band (wristband))

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • BORA Band (wristband)
  • Paris, France
    Pneumology Department - Hôpital Cochin
Mar 6, 2023

COPD, Interstitial Lung Disease Trial in Aveiro (Pulmonary rehabilitation integrating education about palliative care, Pulmonary

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Interstitial Lung Disease
  • Pulmonary rehabilitation integrating education about palliative care
  • Pulmonary rehabilitation
  • Aveiro, Portugal
    University of Aveiro
Sep 13, 2023

COPD Trial in Lahore (ACTIVE CYCLE OF BREATHING TECHNIQUES, SLOW EXPIRATION WITH OPEN GLOTTIS IN LATERAL POSITION)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • ACTIVE CYCLE OF BREATHING TECHNIQUES
  • SLOW EXPIRATION WITH OPEN GLOTTIS IN LATERAL POSITION
  • Lahore, Punjab, Pakistan
    Mayo Hospital
Jun 26, 2023

Pulmonary Disease, Chronic Obstructive Trial in Beijing, Shenzhen, Shanghai (611 300 mg Q2W, 611 450 mg Q2W, Matching )

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • 611 300 mg Q2W
  • +2 more
  • Beijing, Beijing, China
  • +2 more
Oct 25, 2023

COPD Trial in Richmond (Resveratrol, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Resveratrol
  • Placebo
  • Richmond, Virginia
    Virginia Commonwealth University
Jan 31, 2023

COPD, Comorbidities and Coexisting Conditions Trial (NuvoAir Clinical Service)

Not yet recruiting
  • COPD
  • Comorbidities and Coexisting Conditions
  • NuvoAir Clinical Service
  • (no location specified)
Jul 13, 2023

COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection, Rhinovirus Trial (Vapendavir, Placebo)

Not yet recruiting
  • COPD Exacerbation Acute
  • +35 more
  • (no location specified)
Nov 20, 2023

COPD Trial in Osmaniye (Health coaching)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Health coaching
  • Osmaniye, Center, Turkey
    Osmaniye Korkut Ata University
Jan 25, 2023

COPD, Lung Diseases, Obstructive Trial in Shanghai (TCM Daoyin, Health education)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Lung Diseases, Obstructive
  • TCM Daoyin
  • Health education
  • Shanghai, Shanghai, China
  • +1 more
Jul 4, 2023

Chronic Thromboembolic Disease Trial in Amsterdam (Balloon Pulmonary Angioplasty (BPA))

Recruiting
  • Chronic Thromboembolic Disease
  • Balloon Pulmonary Angioplasty (BPA)
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC
Oct 18, 2023

Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)

Not yet recruiting
  • Obesity
  • +4 more
  • Semaglutide Pen Injector
  • (no location specified)
Feb 15, 2023

Acute Exacerbation of COPD, Hypercapnic Acidosis, Respiratory Failure With Hypercapnia Trial in Montpellier, Nimes, Poitiers

Not yet recruiting
  • Acute Exacerbation of Chronic Obstructive Pulmonary Disease
  • +2 more
  • Ventilatory support via nasal high flow
  • Ventilatory support via NIV
  • Montpellier, France
  • +2 more
Nov 6, 2023

COPD Trial in Guangzhou (compound ipratropium bromide solution (3mg salbutamol and 500µg ipratropium, Boehringer Ingelheim

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • compound ipratropium bromide solution (3mg salbutamol and 500μg ipratropium, Boehringer Ingelheim Limited, Germany)
  • Guangzhou, Guangdong, China
    1State Key Laboratory of Respiratory Disease, National clinical
Mar 15, 2023

COPD Trial in Bahawalpur (Nebulizer, Breathing Technique)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Nebulizer
  • Breathing Technique
  • Bahāwalpur, Punjab, Pakistan
    Bahawal Victoria Hospital and Civil Hospital
Jan 4, 2023